{"count": 9, "results": [{"_id": "36964307", "pmid": 36964307, "title": "The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials.", "journal": "Arch Pharm Res", "authors": ["Liu J", "Zhang M", "Deng D", "Zhu X"], "date": "2023-03-24T00:00:00Z", "doi": "10.1007/s12272-023-01445-2", "meta_date_publication": "2023 Mar 24", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.574, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been used clinically for more than 60 years. ", "citations": {"NLM": "Liu J, Zhang M, Deng D, Zhu X. The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials. Arch Pharm Res. 2023 Mar 24;():. PMID: 36964307", "BibTeX": "@article{36964307, title={The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials.}, author={Liu J and Zhang M and Deng D and Zhu X}, journal={Arch Pharm Res}}"}}, {"_id": "34149615", "pmid": 34149615, "pmcid": "PMC8211914", "title": "Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway", "journal": "Front Endocrinol (Lausanne)", "authors": ["Zhao L", "Wu Q", "Wang X", "Wang S", "Shi X", "Shan Z", "Teng W"], "date": "2021-06-04T00:00:00Z", "doi": "10.3389/fendo.2021.659738", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "659738", "score": 50253.105, "text_hl": "Treatment with 2DG and/or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for 4 weeks reversed @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroiditis@@@ in @DISEASE_Thyroiditis_Subacute @DISEASE_MESH:D013968 @@@SAT@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Zhao L, Wu Q, Wang X, Wang S, Shi X, Shan Z, Teng W. Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway Front Endocrinol (Lausanne). 2021;12():659738. PMID: 34149615", "BibTeX": "@article{34149615, title={Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway}, author={Zhao L and Wu Q and Wang X and Wang S and Shi X and Shan Z and Teng W}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={659738}}"}}, {"_id": "32706919", "pmid": 32706919, "title": "The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels.", "journal": "J Clin Pharm Ther", "authors": ["Krysiak R", "Kowalcze K", "Okopień B"], "date": "2020-12-01T00:00:00Z", "doi": "10.1111/jcpt.13233", "meta_date_publication": "2020 Dec", "meta_volume": "45", "meta_issue": "6", "meta_pages": "1382-1389", "score": 50252.562, "text_hl": "The impact of combination therapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and exogenous @CHEMICAL_Vitamin_D @CHEMICAL_MESH:D014807 @@@vitamin D@@@ on hypothalamic-pituitary-@<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid@@@ axis activity in @SPECIES_9606 @@@women@@@ with @DISEASE_Thyroiditis_Autoimmune @DISEASE_MESH:D013967 @@@autoimmune thyroiditis@@@ and high-normal @CHEMICAL_Thyrotropin @CHEMICAL_MESH:D013972 @@@thyrotropin@@@ levels.", "citations": {"NLM": "Krysiak R, Kowalcze K, Okopień B. The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels. J Clin Pharm Ther. 2020 Dec;45(6):1382-1389. PMID: 32706919", "BibTeX": "@article{32706919, title={The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels.}, author={Krysiak R and Kowalcze K and Okopień B}, journal={J Clin Pharm Ther}, volume={45}, number={6}, pages={1382-1389}}"}}, {"_id": "33850550", "pmid": 33850550, "pmcid": "PMC8027752", "title": "Metformin attenuates diabetic renal injury via the AMPK-autophagy axis", "journal": "Exp Ther Med", "authors": ["Sun T", "Liu J", "Xie C", "Yang J", "Zhao L", "Yang J"], "date": "2021-06-01T00:00:00Z", "doi": "10.3892/etm.2021.10010", "meta_date_publication": "2021 Jun", "meta_volume": "21", "meta_issue": "6", "meta_pages": "578", "score": 50250.91, "text_hl": "Increasing evidence suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a characteristic oral hypoglycemic drug used for treating @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, exerts beneficial effects on various medical conditions and diseases, including @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@, @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@ and @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid-related disorders@@@. ", "citations": {"NLM": "Sun T, Liu J, Xie C, Yang J, Zhao L, Yang J. Metformin attenuates diabetic renal injury via the AMPK-autophagy axis Exp Ther Med. 2021 Jun;21(6):578. PMID: 33850550", "BibTeX": "@article{33850550, title={Metformin attenuates diabetic renal injury via the AMPK-autophagy axis}, author={Sun T and Liu J and Xie C and Yang J and Zhao L and Yang J}, journal={Exp Ther Med}, volume={21}, number={6}, pages={578}}"}}, {"_id": "40814473", "pmid": 40814473, "title": "To study effects of metformin on thyroid functions in type-2 diabetes mellitus in patients attending OPD at Government Medical College, Bidar.", "journal": "J Family Med Prim Care", "authors": ["Patil P", "Gudage S", "Tondare MB", "Tondare SB", "Ganganahalli P"], "date": "2025-07-01T00:00:00Z", "doi": "10.4103/jfmpc.jfmpc_75_25", "meta_date_publication": "2025 Jul", "meta_volume": "14", "meta_issue": "7", "meta_pages": "2941-2944", "score": 50246.703, "text_hl": "Conclusion: Thyroid-stimulating hormone (TSH) levels may be somewhat or not at all decreased by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Thyroid function monitoring is crucial for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, particularly if they already have @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid problems@@@.", "citations": {"NLM": "Patil P, Gudage S, Tondare MB, Tondare SB, Ganganahalli P. To study effects of metformin on thyroid functions in type-2 diabetes mellitus in patients attending OPD at Government Medical College, Bidar. J Family Med Prim Care. 2025 Jul;14(7):2941-2944. PMID: 40814473", "BibTeX": "@article{40814473, title={To study effects of metformin on thyroid functions in type-2 diabetes mellitus in patients attending OPD at Government Medical College, Bidar.}, author={Patil P and Gudage S and Tondare MB and Tondare SB and Ganganahalli P}, journal={J Family Med Prim Care}, volume={14}, number={7}, pages={2941-2944}}"}}, {"_id": "32791889", "pmid": 32791889, "title": "Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.", "journal": "Thyroid", "authors": ["Shin HS", "Sun HJ", "Whang YM", "Park YJ", "Park DJ", "Cho SW"], "date": "2021-05-01T00:00:00Z", "doi": "10.1089/thy.2019.0851", "meta_date_publication": "2021 May", "meta_volume": "31", "meta_issue": "5", "meta_pages": "760-771", "score": 50240.61, "text_hl": "...Background: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has antitumoral actions in @SPECIES_9606 @@@human@@@ @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancers@@@, including the @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid@@@, while its effects on metastatic lesions are unclear. ", "citations": {"NLM": "Shin HS, Sun HJ, Whang YM, Park YJ, Park DJ, Cho SW. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions. Thyroid. 2021 May;31(5):760-771. PMID: 32791889", "BibTeX": "@article{32791889, title={Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.}, author={Shin HS and Sun HJ and Whang YM and Park YJ and Park DJ and Cho SW}, journal={Thyroid}, volume={31}, number={5}, pages={760-771}}"}}, {"_id": "24783035", "pmid": 24783035, "title": "Metformin and thyroid: an update.", "journal": "Eur Thyroid J", "authors": ["Pappa T", "Alevizaki M"], "date": "2013-03-01T00:00:00Z", "doi": "10.1159/000346248", "meta_date_publication": "2013 Mar", "meta_volume": "2", "meta_issue": "1", "meta_pages": "22-8", "score": 50089.59, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid@@@: an update.", "citations": {"NLM": "Pappa T, Alevizaki M. Metformin and thyroid: an update. Eur Thyroid J. 2013 Mar;2(1):22-8. PMID: 24783035", "BibTeX": "@article{24783035, title={Metformin and thyroid: an update.}, author={Pappa T and Alevizaki M}, journal={Eur Thyroid J}, volume={2}, number={1}, pages={22-8}}"}}, {"_id": "28196954", "pmid": 28196954, "title": "Metformin and thyroid disease.", "journal": "J Endocrinol", "authors": ["Meng X", "Xu S", "Chen G", "Derwahl M", "Liu C"], "date": "2017-04-01T00:00:00Z", "doi": "10.1530/JOE-16-0450", "meta_date_publication": "2017 Apr", "meta_volume": "233", "meta_issue": "1", "meta_pages": "R43-R51", "score": 50071.36, "text_hl": "Accordingly, @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have a smaller @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroid@@@ volume and a lower risk of incident @DISEASE_Goiter @DISEASE_MESH:D006042 @@@goiter@@@, @DISEASE_Thyroid_Nodule @DISEASE_MESH:D016606 @@@thyroid nodule@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@. ", "citations": {"NLM": "Meng X, Xu S, Chen G, Derwahl M, Liu C. Metformin and thyroid disease. J Endocrinol. 2017 Apr;233(1):R43-R51. PMID: 28196954", "BibTeX": "@article{28196954, title={Metformin and thyroid disease.}, author={Meng X and Xu S and Chen G and Derwahl M and Liu C}, journal={J Endocrinol}, volume={233}, number={1}, pages={R43-R51}}"}}, {"_id": "26895275", "pmid": 26895275, "title": "The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Krysiak R", "Szkrobka W", "Okopien B"], "date": "2016-02-01T00:00:00Z", "doi": "10.1055/s-0035-1565207", "meta_date_publication": "2016 Feb", "meta_volume": "124", "meta_issue": "2", "meta_pages": "71-6", "score": 50057.246, "text_hl": "The aim of this study was to investigate the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on hypothalamic-pituitary-thyroid axis activity in @SPECIES_9606 @@@patients@@@ with interferon-induced @<m>DISEASE_Thyroiditis</m> @DISEASE_MESH:D013966 @@@thyroiditis@@@. ", "citations": {"NLM": "Krysiak R, Szkrobka W, Okopien B. The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study. Exp Clin Endocrinol Diabetes. 2016 Feb;124(2):71-6. PMID: 26895275", "BibTeX": "@article{26895275, title={The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study.}, author={Krysiak R and Szkrobka W and Okopien B}, journal={Exp Clin Endocrinol Diabetes}, volume={124}, number={2}, pages={71-6}}"}}]}